20 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35506019 | Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib. | 2022 | 1 |
2 | 34873472 | CDKN1A/p21WAF1, RB1, ARID1A, FLG, and HRNR mutation patterns provide insights into urinary tract environmental exposure carcinogenesis and potential treatment strategies. | 2021 | 1 |
3 | 32165095 | Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. | 2020 Aug | 2 |
4 | 32173903 | Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression. | 2020 Jun | 2 |
5 | 32229099 | Ribociclib mitigates cisplatin-associated kidney injury through retinoblastoma-1 dependent mechanisms. | 2020 Jul | 2 |
6 | 30466007 | Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice. | 2019 Feb | 1 |
7 | 28403784 | Synthesis, Characterization of 4-Anilino-6,7-Dimethoxy Quinazoline Derivatives as Potential Anti-Angiogenic Agents. | 2018 Feb 7 | 1 |
8 | 29682192 | ATM/RB1 mutations predict shorter overall survival in urothelial cancer. | 2018 Mar 30 | 1 |
9 | 27825116 | Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition. | 2017 Apr 18 | 1 |
10 | 28734226 | Inhibition of pRB Pathway Differentially Modulates Apoptosis in Esophageal Cancer Cells. | 2017 Oct | 3 |
11 | 26238431 | Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer. | 2015 Dec | 1 |
12 | 23521104 | Bioresorbable polymersomes for targeted delivery of cisplatin. | 2013 Apr 17 | 3 |
13 | 24085287 | Anti-apoptotic effect of clusterin on cisplatin-induced cell death of retinoblastoma cells. | 2013 Dec | 1 |
14 | 22759219 | The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide. | 2012 Sep | 1 |
15 | 20428827 | miRNA-regulated expression of oncogenes and tumor suppressor genes in the cisplatin-inhibited growth of K562 cells. | 2010 Jun | 2 |
16 | 19550397 | Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin. | 2009 Jun | 1 |
17 | 16799811 | Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng. | 2007 Feb | 1 |
18 | 17351393 | G1 arrest induction represents a critical determinant for cisplatin cytotoxicity in G1 checkpoint-retaining human cancers. | 2007 Apr | 2 |
19 | 16413407 | S-phase arrest by reactive nitrogen species is bypassed by okadaic acid, an inhibitor of protein phosphatases PP1/PP2A. | 2006 Jan 15 | 1 |
20 | 15492778 | Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review). | 2004 Nov | 2 |